Therapy Areas: Devices
GIE Medical commences patient enrolment for Chronic Benign Stricture - Bowel (PATENT-B) study
19 April 2024 - GIE Medical, a US-based, clinical stage company, announced on Thursday that it has enrolled the first patient for its Paclitaxel Coated Balloon for the treatment of Chronic Benign Stri...
Getinge attains EU MDR approval for Advanta V12 stent system
11 April 2024 - Medical technology company Getinge (STO:GETI-B) announced on Thursday that it has obtained EU MDR approval for its Advanta V12 covered stent system, specifically designated for patient...
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
10 April 2024 - Cadrenal Therapeutics Inc (Nasdaq: CVKD), a Florida-based biopharmaceutical company, announced on Tuesday that it has received Orphan Drug Designation (ODD) from the United States Food...
Thermo Fisher Scientific unveils ENERGY STAR certified TSX Universal Series ULT Freezers
8 April 2024 - Thermo Fisher Scientific (NYSE:TMO) announced on Wednesday that it has launched its latest line of ultra-low temperature (ULT) freezers, the Thermo Scientific TSX Universal Series ULT F...
Renalys Pharma submits Investigational New Drug application for phase three sparsentan clinical trial in Japan
8 April 2024 - Renalys Pharma, Inc, a Tokyo-based private, late-stage clinical biopharmaceutical company, announced on Sunday that it has submitted an Investigational New Drug (IND) Application to the...
Johnson & Johnson to acquire Shockwave Medical
5 April 2024 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) and cardiovascular medical device company Shockwave Medical Inc (Nasdaq:SWAV) announced on Friday a definitive agr...